Skip to main content
ZVRA logo

ZVRA · Zevra Therapeutics, Inc. · Share Buybacks

Track ZVRA — free
$9.19 -0.09 (-0.97%) Play latest call Q3 2026 earnings call transcript
Market Cap
$552.20M
Shares
59.50M
Volume · Nov 19 72.54K Avg daily vol (3M) 954.6K

Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.

Program Authorized
$50,000,000
as of 2021-12-20 · not restated in filings since 2024-11-13

Equity Offering (ATM) Programs

Program Established Capacity Remaining Runs Through
2024-07-12 $75,000,000 — —

Cash spent on buybacks by quarter

Cash deployed each quarter. Δ marks quarters derived from the company's cumulative year-to-date disclosures.

Repurchase History

Fiscal Year Ended Cash Spent
2024-12-31 $0
2023-12-31 $3,447,000
2022-12-31 $4,723,000
2021-12-31 $2,814,000
2020-12-31 $0

Share counts and average prices are restated onto today's share basis across later stock splits; cash spent is as reported. ‡ marks a row kept as filed because a later split could not be attributed to this stock's shares.

Key facts CIK 1434647 CUSIP 488445206 13F (30d) 188 filings 164 filers Visit website Investor relations